Bullfrog ai strengthens scientific advisory board with the addition of gsk veteran and industry pioneer dr. john baldoni

Gaithersburg, md., oct. 15, 2024 (globe newswire) -- bullfrog ai, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of john baldoni, ph.d., to its scientific advisory board. dr. baldoni brings over four decades of experience in the pharmaceutical industry, including leadership roles in scientific research and technology-driven drug discovery.
BFRG Ratings Summary
BFRG Quant Ranking